Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.110
+0.020 (0.96%)
At close: Oct 23, 2026, 4:00 PM EDT
2.128
+0.018 (0.87%)
After-hours: Oct 23, 2026, 7:59 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $252.82 million as of October 23, 2026. It is the 19,212th most valuable company in the world and the 3,354th biggest in the United States. Its market cap has increased by 47.16% in one year.
Market Cap
252.82M
Enterprise Value
174.73M
1-Year Change
47.16%
Global Rank
Country Rank
#3,354 United States
Category
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $252.82M, an increase of 100.49%. That is a compound annual growth rate of 5.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 252.82M | 122.95% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 260.22M |
| Q32 Bio | 257.51M |
| Lineage Cell Therapeutics | 255.44M |
| Vicore Pharma Holding AB | 252.97M |
| Abeona Therapeutics | 251.90M |
| Rocket Pharmaceuticals | 250.83M |
| Ocugen | 250.33M |
| Clinuvel Pharmaceuticals | 249.19M |